| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 01/14/2004 | CN1468211A Nitroso diphenylamine derivatives |
| 01/14/2004 | CN1468207A New retinoids for the treatment of emphysema |
| 01/14/2004 | CN1134506C Thermoplastic resin composition |
| 01/14/2004 | CN1134457C New alpha-aminoacetophenone photoinitiators |
| 01/14/2004 | CN1134423C Adhesion receptor antagonists |
| 01/14/2004 | CN1134414C Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 01/13/2004 | US6677454 Piperidine monoamine transporter ligands, comprising functional group capable of chelating radionuclides |
| 01/13/2004 | US6677451 Polymer stabilizers; oxygen, heat, radiation resistances; discoloration inhibition; coatings; fibers; tapes; films; papermaking; hals; fireproofing; oxidation of a 1-allyl-substituted sterically hindered amine |
| 01/13/2004 | US6677378 Monoamine reuptake inhibitors for treatment of CNS disorders |
| 01/13/2004 | US6677369 Antithrombotic agents |
| 01/13/2004 | US6677354 Treating sleep, brain, sexual, cardiovascular, nervous system, psychological, glandular, and gastrointestinal disorders |
| 01/13/2004 | US6677332 Amide-substituted piperidine or azepine derivatives to treat drug abuse and tinnitus |
| 01/13/2004 | US6677330 Acetylcholinesterase inhibitors; treating alzheimer*s disease, attention deficit, hyperactivity and brain disorders |
| 01/13/2004 | US6677308 Integrin antagonists; antitumor, antimetastasis, anticarcinogenic agents; angiogenesis and restenosis inhibitors; osteoporosis |
| 01/13/2004 | US6676968 Release-regulating preparations comprising biphenyldiamine derivatives |
| 01/08/2004 | WO2004002959A1 Novel azasugar derivative and drug containing the same as the active ingredient |
| 01/08/2004 | WO2004002958A1 Industrial process for the synthesis of isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridine dicarboxylate (nisoldipine) |
| 01/08/2004 | WO2004002957A1 Novel tetrahydropyridine derivatives as renin inhibitors |
| 01/08/2004 | WO2004002948A1 Amide compound and medicinal use thereof |
| 01/08/2004 | WO2004002944A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002940A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002549A1 Use of organic compounds |
| 01/08/2004 | WO2004002531A1 Remedies for diseases caused by vascular contraction or dilation |
| 01/08/2004 | WO2004002483A1 Substituted 3- and 4- aminomethylpiperidines for use as beta-secretase in the treatment of alzheimer’s disease |
| 01/08/2004 | WO2003084928A8 Alpha, omega-dicarboximide derivatives as useful uro-selective α1α adrenoceptor blockers |
| 01/08/2004 | WO2002056745A3 Method of treating parkinson's disease |
| 01/08/2004 | US20040006235 Process for the preparation of ring compounds |
| 01/08/2004 | US20040006233 Synthetic multimerizing agents |
| 01/08/2004 | US20040006110 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
| 01/08/2004 | US20040006107 For prophylaxis of asthma and other allergic diseases |
| 01/08/2004 | US20040006106 For therapy of breast cancer in mammals |
| 01/08/2004 | US20040006089 For therapy of acromegalia, hypophyseal adenomas or endocrine gastroenteropancreatic tumors including carcinoid syndrome |
| 01/08/2004 | US20040006081 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 01/08/2004 | US20040006080 Chemical compounds |
| 01/08/2004 | US20040006078 For therapy of autoimmune diseases, asthma, osteoporosis, atherosclerosis, Alzheimer's disease |
| 01/08/2004 | US20040006069 For therapy inflammatory and immune system disorders such as stroke, myocardial infarction, atherosclerosis, ischemic heart disease, ischemia-reperfusion injury |
| 01/08/2004 | US20040006067 Substituted piperidines and methods of use |
| 01/08/2004 | US20040006062 For use as anticoagulant agents for therapy of thromboembolic disorders |
| 01/08/2004 | CA2494249A1 Novel azasugar derivative and drug containing the same as the active ingredient |
| 01/08/2004 | CA2491156A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | CA2490950A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | CA2490811A1 Use of organic compounds |
| 01/08/2004 | CA2490138A1 Novel tetrahydropyridine derivatives as renin inhibitors |
| 01/07/2004 | EP1378509A1 Drugs containing triazaspiro 5.5]undecane derivatives as the active ingredient |
| 01/07/2004 | EP1378508A1 Various forms of paroxetine hydrochloride anhydrate |
| 01/07/2004 | EP1378247A1 Visual function improving agents |
| 01/07/2004 | EP1378238A1 Pharmaceutical compositions containing donepezil hydrochloride |
| 01/07/2004 | EP1377543A1 Oxalic acid derivatives |
| 01/07/2004 | EP1377295A2 Carboxamide derivatives as therapeutic agents |
| 01/07/2004 | EP1377293A1 Aryl and biaryl piperidines used as mch antagonists |
| 01/07/2004 | EP1377290A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 01/07/2004 | EP1056733B1 Histamine h3 receptor ligands |
| 01/07/2004 | CN1466573A 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis |
| 01/07/2004 | CN1466455A Fentanyl composition for nasal administration |
| 01/07/2004 | CN1133622C Ureidopiperidine derivatives as selective human NK3 receptor antagonists |
| 01/07/2004 | CN1133372C Insecticidal N-(substituted arylmethyl)-4-[bis(substituted phenyl or pyridyl)methyl] piperidines |
| 01/06/2004 | US6673933 1-(3-(4-(1,1-bis(alkyoxycarbonyl)alkyl)phenyl)carbonylpropyl), 4-(hydroxydiphenylmethyl)piperidine |
| 01/06/2004 | US6673931 (4-(4-(3-(2-methoxy-benzyloxy)-propoxy)-phenyl)-5-(4-methoxy -naphthalen-2-ylmethoxy)-piperidin-3-yl)-methanol for example; use treating restenosis, glaucoma, cardiac and kidney insufficiency |
| 01/06/2004 | US6673920 Method for the production of N-alkenyl-amides |
| 01/06/2004 | US6673829 Treatment of diseases of the central nervous system, the peripheral nervous system, the cardiovascular system, the pulmonary system, the gastrointestinal system and the endocrinological system. |
| 01/06/2004 | US6673817 Anticoagulants |
| 01/06/2004 | US6673803 Quinazoline derivatives and pharmaceutical compositions containing them |
| 01/06/2004 | US6673555 Methods of using SCAP antagonists |
| 01/02/2004 | EP1375482A1 Benzamidine derivative |
| 01/02/2004 | EP1375476A1 A new process for the synthesis of alkoxyamines active in controlled radical polymerization |
| 01/02/2004 | EP1375457A1 One-pot process for the preparation of functionalized alkoxyamines |
| 01/02/2004 | EP1373272A2 Tert. alkylphenoxy substituted polycyclic compounds |
| 01/02/2004 | EP1373262A2 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors |
| 01/02/2004 | EP1373251A2 Non-imidazole compounds as histamine h3 antagonists |
| 01/02/2004 | EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2004 | EP1373223A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 01/02/2004 | EP1373221A2 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 01/02/2004 | EP1373207A1 Novel amlodipine camsylate and method for preparing thereof |
| 01/02/2004 | EP1373205A1 Novel piperidine derivatives as modulators of chemokine receptors |
| 01/02/2004 | EP1373195A2 Quaternary amino acids on solid supports |
| 01/02/2004 | EP1373194A1 BENZAMIDE INHIBITORS OF FACTOR Xa |
| 01/02/2004 | EP1373188A1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics |
| 01/02/2004 | EP1372692A2 Asymmetric synthesis of (s, s, r)-(-)-actinonin and its analogs and uses therefor |
| 01/02/2004 | EP1372657A2 A method of treating proliferative diseases using eg5 inhibitors |
| 01/02/2004 | EP1372655A2 Cathepsin cysteine protease inhibitors |
| 01/02/2004 | EP1372653A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 01/02/2004 | EP1036062B1 Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors |
| 01/02/2004 | EP1027339B1 Method and reagents for n-alkylating ureides |
| 01/01/2004 | US20040002606 Reacting a secondary amine with oxidizer; one pot process |
| 01/01/2004 | US20040002604 Phenylalkynes |
| 01/01/2004 | US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device |
| 01/01/2004 | US20040002521 Antiinflammatory agents; metalloprotease inhibitor; antiarthritic agents; antiallergens; viricides |
| 01/01/2004 | US20040002517 Alzheimer's disease |
| 01/01/2004 | US20040002515 Antihistamines; antiallergens; antiinflammatory agents; autoimmune diseases; rheumatic diseases |
| 01/01/2004 | US20040002504 Psychological disorders; schizophrenia |
| 01/01/2004 | US20040002503 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 01/01/2004 | US20040002461 Amelioration of the development of cataracts and other ophthalmic diseases |
| 12/31/2003 | WO2004000828A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders |
| 12/31/2003 | WO2004000827A1 Method for producing carbonyl compounds |
| 12/31/2003 | WO2004000825A1 Novel compounds |
| 12/31/2003 | WO2004000811A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors |
| 12/31/2003 | WO2004000809A1 Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays |
| 12/31/2003 | WO2004000808A2 N-substituted piperidine derivatives as serotonin receptor agents |
| 12/31/2003 | WO2004000806A1 Amides of cyclic amino acids used as pde 4 inhibitors |
| 12/31/2003 | WO2004000789A1 Amide linker peroxisome proliferator activated receptor modulators |